A dramatic production acceleration is underway at Boeing, even as the aerospace titan grapples with the staggering financial fallout from its troubled 777X program. The company finds itself navigating a complex landscape where regulatory approval to increase output of its cash-generating 737 MAX model clashes with multi-billion dollar losses from another segment of its business.
A Financial Picture of Extremes
The latest quarterly report presents a study in contrasts. Boeing’s revenue surged impressively by 30 percent to reach $23.3 billion, demonstrating robust demand for its aircraft. However, this positive performance was dramatically offset by a colossal quarterly loss of $5.4 billion. The primary driver behind this deficit was a substantial $4.9 billion charge directly attributable to ongoing issues with the 777X program, which has encountered another significant delay pushing its first delivery to 2027.
Manufacturing Momentum Builds
In a decisive move to clear its substantial order backlog, Boeing is making aggressive investments to expand manufacturing capacity. The company is channeling over one billion dollars into a major expansion of its South Carolina facility, where the 787 Dreamliner is produced. This project will nearly double the size of the plant and is expected to create more than 1,000 new employment opportunities. Boeing has set an ambitious target to achieve a production rate of ten Dreamliners per month by 2026.
In another crucial development, the Federal Aviation Administration has authorized Boeing to increase monthly production of its 737 MAX aircraft. The company can now ramp up output from 38 to 42 units monthly, effectively lifting an artificial cap that had constrained production for over two years. This regulatory green light represents a significant milestone for Boeing’s most commercially important aircraft program.
Should investors sell immediately? Or is it worth buying Boeing?
Global Demand Underpins Operations
Boeing’s order book continues to reflect strong international demand, securing a solid foundation for future operations:
- Tajikistan’s Somon Air placed an order for up to 14 aircraft, marking the largest purchase in the airline’s history
- Air Astana of Kazakhstan is modernizing its long-haul fleet with an order for as many as 15 Dreamliner aircraft
- Australian supplier AW Bell is supporting production of the 737 and 777 models through new casting components
Despite these positive indicators, market observers question whether these developments are sufficient to reverse Boeing’s downward trajectory. While financial analysts generally view the aggressive production targets as a step in the right direction, they simultaneously urge caution. Concerns persist that strained supply chains for critical materials could potentially hinder the planned production increases, thereby jeopardizing the company’s anticipated financial recovery.
The battle for Boeing’s turnaround is intensifying. As manufacturing operations gain momentum, the substantial financial burdens from the 777X program continue to exert significant pressure on the company’s stock performance.
Ad
Boeing Stock: Buy or Sell?! New Boeing Analysis from November 10 delivers the answer:
The latest Boeing figures speak for themselves: Urgent action needed for Boeing investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 10.
Boeing: Buy or sell? Read more here...










